59 related articles for article (PubMed ID: 31691036)
1. Regulatory T cells and M2 macrophages present diverse prognostic value in gastric cancer patients with different clinicopathologic characteristics and chemotherapy strategies.
Liu X; Xu D; Huang C; Guo Y; Wang S; Zhu C; Xu J; Zhang Z; Shen Y; Zhao W; Zhao G
J Transl Med; 2019 Jun; 17(1):192. PubMed ID: 31174544
[TBL] [Abstract][Full Text] [Related]
2. Tumour infiltrating lymphocytes and survival after adjuvant chemotherapy in patients with gastric cancer: post-hoc analysis of the CLASSIC trial.
Liu DHW; Kim YW; Sefcovicova N; Laye JP; Hewitt LC; Irvine AF; Vromen V; Janssen Y; Davarzani N; Fazzi GE; Jolani S; Melotte V; Magee DR; Kook MC; Kim H; Langer R; Cheong JH; Grabsch HI
Br J Cancer; 2023 Jun; 128(12):2318-2325. PubMed ID: 37029200
[TBL] [Abstract][Full Text] [Related]
3. Chilean Gastric Cancer Task Force: A study protocol to obtain a clinical and molecular classification of a cohort of gastric cancer patients.
Owen GI; Pinto MP; Retamal IN; Fernádez MF; Cisternas B; Mondaca S; Sanchez C; Galindo H; Nervi B; Ibañez C; Acevedo F; Madrid J; Peña J; Bravo ML; Maturana MJ; Cordova-Delgado M; Romero D; de la Jara N; Torres J; Rodriguez-Fernandez M; Espinoza M; Balmaceda C; Freire M; Gárate-Calderón V; Crovari F; Jimenez-Fonseca P; Carmona-Bayonas A; Zwenger A; Armisen R; Corvalan AH; Garrido M
Medicine (Baltimore); 2018 Apr; 97(16):e0419. PubMed ID: 29668600
[TBL] [Abstract][Full Text] [Related]
4. The Remarkable Plasticity of Macrophages: A Chance to Fight Cancer.
Bercovici N; Guérin MV; Trautmann A; Donnadieu E
Front Immunol; 2019; 10():1563. PubMed ID: 31354719
[TBL] [Abstract][Full Text] [Related]
5. Whole-Slide Image Analysis Reveals Quantitative Landscape of Tumor-Immune Microenvironment in Colorectal Cancers.
Yoo SY; Park HE; Kim JH; Wen X; Jeong S; Cho NY; Gwon HG; Kim K; Lee HS; Jeong SY; Park KJ; Han SW; Kim TY; Bae JM; Kang GH
Clin Cancer Res; 2020 Feb; 26(4):870-881. PubMed ID: 31757879
[TBL] [Abstract][Full Text] [Related]
6. Intrahepatic cholangiocarcinomas with IDH1/2 mutation-associated hypermethylation at selective genes and their clinicopathological features.
Lee K; Song YS; Shin Y; Wen X; Kim Y; Cho NY; Bae JM; Kang GH
Sci Rep; 2020 Sep; 10(1):15820. PubMed ID: 32978444
[TBL] [Abstract][Full Text] [Related]
7. SMOC2, an intestinal stem cell marker, is an independent prognostic marker associated with better survival in colorectal cancers.
Jang BG; Kim HS; Bae JM; Kim WH; Kim HU; Kang GH
Sci Rep; 2020 Sep; 10(1):14591. PubMed ID: 32884102
[TBL] [Abstract][Full Text] [Related]
8. Biparametric versus multiparametric magnetic resonance imaging of the prostate: detection of clinically significant cancer in a perfect match group.
Cho J; Ahn H; Hwang SI; Lee HJ; Choe G; Byun SS; Hong SK
Prostate Int; 2020 Dec; 8(4):146-151. PubMed ID: 33425791
[TBL] [Abstract][Full Text] [Related]
9. Identification of a molecular signature of prognostic subtypes in diffuse-type gastric cancer.
Kim SK; Kim HJ; Park JL; Heo H; Kim SY; Lee SI; Song KS; Kim WH; Kim YS
Gastric Cancer; 2020 May; 23(3):473-482. PubMed ID: 31773340
[TBL] [Abstract][Full Text] [Related]
10. The prognostic value of the tertiary lymphoid structure in gastrointestinal cancers.
Yu A; Cao M; Zhang K; Yang Y; Ma L; Zhang X; Zhao Y; Ma X; Fan Z; Han Z; Wang H
Front Immunol; 2023; 14():1256355. PubMed ID: 37868990
[TBL] [Abstract][Full Text] [Related]
11. Research progress of LINE-1 in the diagnosis, prognosis, and treatment of gynecologic tumors.
Fu J; Qin T; Li C; Zhu J; Ding Y; Zhou M; Yang Q; Liu X; Zhou J; Chen F
Front Oncol; 2023; 13():1201568. PubMed ID: 37546391
[TBL] [Abstract][Full Text] [Related]
12. Immunology and immunotherapy in gastric cancer.
Xu X; Chen J; Li W; Feng C; Liu Q; Gao W; He M
Clin Exp Med; 2023 Nov; 23(7):3189-3204. PubMed ID: 37322134
[TBL] [Abstract][Full Text] [Related]
13. The relationship between tumour infiltrating lymphocytes, Epstein-Barr virus and
Castañeda C; Castillo M; Bernabe L; Suarez N; Fassan M; Sanchez J; Tello K; Alatrista R; Chavez I; Ruiz E; Bazan Y; Barreda F; Valdivia D; Meng W; Chakravarti A; Sanchez J; Taxa L; Montenegro P
Ecancermedicalscience; 2022; 16():1362. PubMed ID: 35685959
[TBL] [Abstract][Full Text] [Related]
14. Assessment of copy number in protooncogenes are predictive of poor survival in advanced gastric cancer.
Li M; Kim Y; Kim TS; Cho NY; Bae JM; Kim WH; Kang GH
Sci Rep; 2021 Jun; 11(1):12117. PubMed ID: 34108525
[TBL] [Abstract][Full Text] [Related]
15. Combination of L1 methylation and tumor-infiltrating lymphocytes as prognostic marker in advanced gastric cancer.
Kim Y; Rhee YY; Wen X; Cho NY; Bae JM; Kim WH; Kang GH
Gastric Cancer; 2020 May; 23(3):464-472. PubMed ID: 31691036
[TBL] [Abstract][Full Text] [Related]
16. Combinatory low methylation statuses of SAT-α and L1 are associated with shortened survival time in patients with advanced gastric cancer.
Kim Y; Wen X; Jeong S; Cho NY; Kim WH; Kang GH
Gastric Cancer; 2019 Jan; 22(1):37-47. PubMed ID: 29926315
[TBL] [Abstract][Full Text] [Related]
17. The expression of C-MYC in gastric adenocarcinoma is associated with PD-L1 and FOXP3 expression: C-MYC overexpression is a good prognostic factor.
Won KY; Kim GY; Kim HK; Song MJ; Choi SI; Bae GE; Lim SJ
Pathol Res Pract; 2019 Nov; 215(11):152639. PubMed ID: 31582185
[TBL] [Abstract][Full Text] [Related]
18. Prognostic implications and interaction of L1 methylation and p53 expression statuses in advanced gastric cancer.
Shin YJ; Kim Y; Wen X; Cho NY; Lee S; Kim WH; Kang GH
Clin Epigenetics; 2019 May; 11(1):77. PubMed ID: 31088544
[TBL] [Abstract][Full Text] [Related]
19. Methylation statuses of NCOR2, PARK2, and ZSCAN12 signify densities of tumor-infiltrating lymphocytes in gastric carcinoma.
Wen X; Jin HY; Li M; Kim Y; Cho NY; Kwak Y; Bae JM; Lee HS; Kang GH
Sci Rep; 2022 Jan; 12(1):862. PubMed ID: 35039565
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
